Hyperliquid Strategies Inc (Nasdaq: PURR) filed an amended registration statement on Form S-1/A with the U.S. Securities and Exchange Commission dated June 25, 2026. The preliminary prospectus, marked subject to completion, covers a resale offering and describes the company's digital-asset treasury strategy. This piece reports what the document states; it does not assess the strategy, the company's securities, or the future price of any digital asset, and it offers no buy, sell, or hold view.

According to the prospectus, the filing relates to the potential resale from time to time by Rorschach Advisors LLC, identified as the "Advisor" or "Selling Securityholder," of up to 35,156,660 shares of common stock. The filing states this consists of 7,761,860 shares already issued to the Advisor and 27,394,800 shares issuable upon exercise of warrants, all issued in connection with a business combination. It is explicit that this is a resale registration: "We will not receive any of the proceeds from the sale by the Selling Securityholder of the Advisor Shares." The prospectus adds that, assuming issuance of all warrant shares and the sale of all registered shares, the Advisor Shares would represent approximately 17.9% of outstanding common stock as of June 15, 2026, and cautions that such sales, or the perception of them, could result in a significant decline in the trading price. The shares trade on Nasdaq under "PURR," with a last reported sale price of $9.34 on June 15, 2026.

The filing describes the company's treasury approach. It defines "HYPE Token" as the native token of the Hyperliquid Layer 1 blockchain and refers throughout to the company's "HYPE treasury strategy." The document states the company has adopted ASU 2023-08, which requires it to measure its HYPE holdings at fair value and to recognize gains and losses from changes in that fair value in net income each reporting period. The prospectus traces the company's formation to a business combination completed on December 2, 2025 involving Sonnet BioTherapeutics Holdings, Inc. and Rorschach I LLC, at which certain investors contributed HYPE and cash to Rorschach. The filing states that at closing the company held approximately $580 million in HYPE tokens (based on an agreed spot price of $46.372) and had cash of approximately $310 million before transaction expenses.

On subsequent funding, the prospectus discloses a committed equity facility entered into on October 22, 2025 with Chardan Capital Markets LLC, under which the company may direct Chardan to purchase up to $1.0 billion of common stock. From the commencement date through June 15, 2026, the filing states the company issued approximately 70.2 million shares generating net proceeds of approximately $588 million "that was primarily used to purchase HYPE tokens," and that it currently plans to use proceeds from any additional sales primarily for potential HYPE purchases and general corporate purposes.

The S-1/A devotes substantial space to risk factors tied to that concentration, stating that any future significant decline in the price of HYPE would have a more pronounced impact on the company's financial condition than a more diversified portfolio would. It summarizes the concentration this way:

"The concentration of our HYPE holdings limits the risk mitigation that we could achieve if we were to purchase a more diversified portfolio of treasury assets, and the absence of diversification enhances the risks inherent in our HYPE treasury strategy."— Hyperliquid Strategies Inc Form S-1/A, source

Among other framing, the filing states that the HYPE treasury strategy subjects the company to enhanced regulatory oversight, that loss of banking relationships could affect its ability to execute the strategy, and that because it only recently initiated the strategy, its historical financial statements do not reflect the potential earnings variability it may experience from holding or selling significant amounts of HYPE. The company also notes it is an "emerging growth company" and a "smaller reporting company" subject to reduced reporting requirements. The full S-1/A is available on sec.gov.